Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trial
Resource Type
Article
Authors
Ladenstein, Ruth ; Pötschger, Ulrike ; Pearson, Andrew D J ; Brock, Penelope ; Luksch, Roberto ; Castel, Victoria ; Yaniv, Isaac ; Papadakis, Vassilios ; Laureys, Geneviève ; Malis, Josef ; Balwierz, Walentyna ; Ruud, Ellen ; Kogner, Per ; Schroeder, Henrik ; de Lacerda, Ana Forjaz ; Beck-Popovic, Maja ; Bician, Pavel ; Garami, Miklós ; Trahair, Toby ; Canete, Adela ; Ambros, Peter F ; Holmes, Keith ; Gaze, Mark ; Schreier, Günter ; Garaventa, Alberto ; Vassal, Gilles ; Michon, Jean ; Valteau-Couanet, Dominique
Source
In The Lancet Oncology April 2017 18(4):500-514
Subject
Primary Research Articles
Language
ISSN
1470-2045